These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 25791711)

  • 1. Cerebral Cavernous Malformation-1 Protein Controls DLL4-Notch3 Signaling Between the Endothelium and Pericytes.
    Schulz GB; Wieland E; Wüstehube-Lausch J; Boulday G; Moll I; Tournier-Lasserve E; Fischer A
    Stroke; 2015 May; 46(5):1337-43. PubMed ID: 25791711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.
    Zhu Y; Wu Q; Xu JF; Miller D; Sandalcioglu IE; Zhang JM; Sure U
    Neurosurg Focus; 2010 Sep; 29(3):E1. PubMed ID: 20809750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations.
    Zheng X; Xu C; Di Lorenzo A; Kleaveland B; Zou Z; Seiler C; Chen M; Cheng L; Xiao J; He J; Pack MA; Sessa WC; Kahn ML
    J Clin Invest; 2010 Aug; 120(8):2795-804. PubMed ID: 20592472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations.
    You C; Sandalcioglu IE; Dammann P; Felbor U; Sure U; Zhu Y
    J Cell Mol Med; 2013 Mar; 17(3):407-18. PubMed ID: 23388056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mural Cell-Specific Deletion of Cerebral Cavernous Malformation 3 in the Brain Induces Cerebral Cavernous Malformations.
    Wang K; Zhang H; He Y; Jiang Q; Tanaka Y; Park IH; Pober JS; Min W; Zhou HJ
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2171-2186. PubMed ID: 32640906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro characterization of the angiogenic phenotype and genotype of the endothelia derived from sporadic cerebral cavernous malformations.
    Zhu Y; Wu Q; Fass M; Xu JF; You C; Müller O; Sandalcioglu IE; Zhang JM; Sure U
    Neurosurgery; 2011 Sep; 69(3):722-31; discussion 731-2. PubMed ID: 21471841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptojanin-2 binding protein stabilizes the Notch ligands DLL1 and DLL4 and inhibits sprouting angiogenesis.
    Adam MG; Berger C; Feldner A; Yang WJ; Wüstehube-Lausch J; Herberich SE; Pinder M; Gesierich S; Hammes HP; Augustin HG; Fischer A
    Circ Res; 2013 Nov; 113(11):1206-18. PubMed ID: 24025447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling.
    Wüstehube J; Bartol A; Liebler SS; Brütsch R; Zhu Y; Felbor U; Sure U; Augustin HG; Fischer A
    Proc Natl Acad Sci U S A; 2010 Jul; 107(28):12640-5. PubMed ID: 20616044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin cytoplasmic domain-associated protein-1 attenuates sprouting angiogenesis.
    Brütsch R; Liebler SS; Wüstehube J; Bartol A; Herberich SE; Adam MG; Telzerow A; Augustin HG; Fischer A
    Circ Res; 2010 Sep; 107(5):592-601. PubMed ID: 20616313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch Signaling in Familial Cerebral Cavernous Malformations and Immunohistochemical Detection of Cleaved Notch1 Intracellular Domain.
    Hasan SS; Fischer A
    Methods Mol Biol; 2020; 2152():427-435. PubMed ID: 32524570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the vascular endothelial growth factor-Delta-like 4 ligand/Notch4-ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions.
    Hainaud P; Contrerès JO; Villemain A; Liu LX; Plouët J; Tobelem G; Dupuy E
    Cancer Res; 2006 Sep; 66(17):8501-10. PubMed ID: 16951162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrastructural analysis of vascular features in cerebral cavernous malformations.
    Tanriover G; Sozen B; Seker A; Kilic T; Gunel M; Demir N
    Clin Neurol Neurosurg; 2013 Apr; 115(4):438-44. PubMed ID: 22776801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EphB4 forward signalling mediates angiogenesis caused by CCM3/PDCD10-ablation.
    You C; Zhao K; Dammann P; Keyvani K; Kreitschmann-Andermahr I; Sure U; Zhu Y
    J Cell Mol Med; 2017 Sep; 21(9):1848-1858. PubMed ID: 28371279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCM2 expression parallels that of CCM1.
    Seker A; Pricola KL; Guclu B; Ozturk AK; Louvi A; Gunel M
    Stroke; 2006 Feb; 37(2):518-23. PubMed ID: 16373645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANKS1B Interacts with the Cerebral Cavernous Malformation Protein-1 and Controls Endothelial Permeability but Not Sprouting Angiogenesis.
    Herberich SE; Klose R; Moll I; Yang WJ; Wüstehube-Lausch J; Fischer A
    PLoS One; 2015; 10(12):e0145304. PubMed ID: 26698571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.
    Stahl S; Gaetzner S; Voss K; Brackertz B; Schleider E; Sürücü O; Kunze E; Netzer C; Korenke C; Finckh U; Habek M; Poljakovic Z; Elbracht M; Rudnik-Schöneborn S; Bertalanffy H; Sure U; Felbor U
    Hum Mutat; 2008 May; 29(5):709-17. PubMed ID: 18300272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic causes of multiple cerebral cavernous malformations in a Japanese population.
    Tsutsumi S; Ogino I; Miyajima M; Ikeda T; Shindo N; Yasumoto Y; Ito M; Arai H
    J Clin Neurosci; 2013 May; 20(5):667-9. PubMed ID: 23485406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDCD10, the gene mutated in cerebral cavernous malformation 3, is expressed in the neurovascular unit.
    Tanriover G; Boylan AJ; Diluna ML; Pricola KL; Louvi A; Gunel M
    Neurosurgery; 2008 Apr; 62(4):930-8; discussion 938. PubMed ID: 18496199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The vascular delta-like ligand-4 (DLL4)-Notch4 signaling correlates with angiogenesis in primary glioblastoma: an immunohistochemical study.
    Zhang JF; Chen Y; Qiu XX; Tang WL; Zhang JD; Huang JH; Lin GS; Wang XF; Lin ZX
    Tumour Biol; 2016 Mar; 37(3):3797-805. PubMed ID: 26472724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EndMT contributes to the onset and progression of cerebral cavernous malformations.
    Maddaluno L; Rudini N; Cuttano R; Bravi L; Giampietro C; Corada M; Ferrarini L; Orsenigo F; Papa E; Boulday G; Tournier-Lasserve E; Chapon F; Richichi C; Retta SF; Lampugnani MG; Dejana E
    Nature; 2013 Jun; 498(7455):492-6. PubMed ID: 23748444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.